Results 11 to 20 of about 10,281 (182)

Salivary PYY: a putative bypass to satiety. [PDF]

open access: yesPLoS ONE, 2011
Peptide YY(3-36) is a satiation hormone released postprandially into the bloodstream from L-endocrine cells in the gut epithelia. In the current report, we demonstrate PYY(3-36) is also present in murine as well as in human saliva.
Andres Acosta   +11 more
doaj   +4 more sources

Disordered pancreatic and gastrointestinal hormone responses to nutrient stimulation in Zambian children with severe acute malnutrition. [PDF]

open access: yesExp Physiol
Abstract Nutrient sensing enables the body to detect and respond to nutrient availability through hormonal regulation. In this study, we examined nutrient‐stimulated hormonal responses in children with severe acute malnutrition (SAM) compared with hospitalized (HC) and community (CC) child comparators.
Besa E   +9 more
europepmc   +2 more sources

ETV1 is a key regulator of enteroendocrine PYY production [PDF]

open access: yesDisease Models & Mechanisms
ABSTRACT The intestine is a rich source of hormones that regulate metabolism. Among these are glucagon-like peptide-1 (GLP-1) and peptide YY (PYY), both expressed by L-cells. These hormones play important roles in promoting satiety; however, how they are regulated transcriptionally is not known.
Astrid M. Baattrup   +6 more
doaj   +4 more sources

Peptide YY (PYY) Is Expressed in Human Skeletal Muscle Tissue and Expanding Human Muscle Progenitor Cells

open access: yesFrontiers in Physiology, 2019
Peptide YY (PYY) is considered a gut peptide with roles in post-prandial appetite and glucose regulation. Circulating PYY protein levels increase during aerobic exercise.
Brandon J. Gheller   +4 more
doaj   +1 more source

PYY (peptide YY) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2012
Review on PYY (peptide YY), with data on DNA, on the protein encoded, and where the gene is implicated.
Braoudaki, M, Tzortzatou-Stathopoulou, F
openaire   +2 more sources

Effects of 2 Novel PYY(1-36) Analogues, (PLP)PYY(1-36) and PYY(1-36)(LysPAL), on Pancreatic Beta-Cell Function, Growth, and Survival

open access: yesClinical Medicine Insights: Endocrinology and Diabetes, 2019
Recent studies have identified a beneficial role for peptide tyrosine tyrosine (PYY) on pancreatic beta-cell function and survival. These effects are linked to the activation of neuropeptide Y1 receptors (NPYR1s) by PYY(1-36).
Ryan A Lafferty   +3 more
doaj   +1 more source

The effect of peptide tyrosine tyrosine (PYY3–36), a selective Y2 receptor agonist on streptozotocin-induced diabetes in albino rats

open access: yesEndocrine Regulations, 2019
Objective. The aim of the present study was to assess the effect of the PYY3–36, as a potential therapy for the type 2 diabetes mellitus (T2DM), induced by high fat diet (HFD) and an intraperitoneal (i.p.) administration of streptozotocin (STZ) in albino
Abdel-Hamid Heba A.   +3 more
doaj   +1 more source

Neural regulation of hindlimb muscle contraction-induced glucagon-like peptide-1 and peptide YY secretion in rats

open access: yesJournal of Physical Fitness and Sports Medicine, 2015
The physiological mechanisms underlying the increases observed in glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) plasma levels with exercise currently remain unknown.
Shin-ya Ueda   +3 more
doaj   +1 more source

Positive Effects of NPY1 Receptor Activation on Islet Structure Are Driven by Pancreatic Alpha- and Beta-Cell Transdifferentiation in Diabetic Mice

open access: yesFrontiers in Endocrinology, 2021
Enzymatically stable and specific neuropeptide Y1 receptor (NPYR1) agonists, such as sea lamprey PYY(1-36) (SL-PYY(1-36)), are believed to improve glucose regulation in diabetes by targeting pancreatic islets. In this study, streptozotocin (STZ) diabetic
Ryan A. Lafferty   +6 more
doaj   +1 more source

Low bone mineral density is found in low weight female youth with avoidant/restrictive food intake disorder and associated with higher PYY levels

open access: yesJournal of Eating Disorders, 2023
Background Avoidant/restrictive food intake disorder (ARFID) is a restrictive eating disorder commonly associated with medical complications of undernutrition and low weight.
Aluma Chovel Sella   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy